期刊文献+

eotaxin-3基因多态性与变应性哮喘的相关性 被引量:7

The research on the correlation between eotaxin-3 gene polymorphisms and allergic asthma
原文传递
导出
摘要 目的研究eotaxin-3基因多态性与变应性哮喘的相关性。方法用聚合酶链反应-单链构象多态性-四引物聚合酶链反应-限制性酶切的方法对湖北地区汉族成人eotaxin-3+77C/T和+2497T/G单核苷酸多态性与哮喘易感性、嗜酸性粒细胞(eosinophil,EOS)计数以及血浆总IgE水平的相关性进行了分析。结果eotaxin-3+2497位哮喘组与对照组G等位基因的频率,哮喘组IgE浓度及EOS数量差异有统计学意义,P值分别为0.011、0.021和0.029;+77位哮喘组与对照组T等位基因的频率,哮喘组IgE浓度差异无统计学意义,P值分别为0.824和0.473;+77位哮喘组EOS数量差异有统计学意义,P值为0.044。结论eotaxin-3+2497T/G多态性与哮喘易感性、EOS数量及IgE水平相关,+77位C/T基因多态性与哮喘EOS数量相关。 Objective To study in the linkage between eotaxin-3 gene polymorphisms and allergic asthma susceptivity, blood plasma IgE or peripheral blood eosinophil in adult population of Han nationality from Hubei province of China. Methods Polymerase chain reaction (PCR), single strand conformation polymorphism (SSCP), tetra-primer PCR technique and restriction analysis were applied to identify the single nucleotide polymorphism. Results The allele frequency of eotaxin-3 + 2497 G, total levels of plasma IgE and peripheral blood eosinophil counts revealed the significant difference between control and allergic asthma group, that the P value was 0.011, 0.021 or 0.029 respectively. The allele frequency of eotaxin-3 + 77 T and total levels of plasma IgE showed to have no significant difference between control and allergic asthma group, that the P value was 0.824 and 0.473 respectively. However, the peripheral blood eosinophil counts was significantly different between control and allergic asthma group, and the P value was 0. 044. Conclusion Single nucleotide polymorphism of eotaxin-3 + 2497 is associated with the asthma susceptibility, peripheral eosinophil counts and total levels of plasma IgE in adult population from Hubei province, and polymorphism of + 77 is associated with peripheral eosinophil counts.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2006年第2期169-172,共4页 Chinese Journal of Medical Genetics
关键词 eotaxin-3基因 单核苷酸多态性 变应性哮喘 eotaxin-3 gene single nucleotide polymorphism allergic asthma
  • 相关文献

参考文献7

  • 1Griffiths-Johnson DA, Collins PD, Rossi AG, et al. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro, and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun, 1993, 197: 1167-1172.
  • 2Kampen GT, Stafford S, Adachi T, et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen2 activated protein kinases. Blood, 2000, 95 : 19112-19117.
  • 3Shin HD, Kim LH, Park BL, et al. Association of eotaxin gene family with asthma and serum total IgE. Hum Mol Genet,2003, 12: 1279-1285.
  • 4Chae SC, Lee YC, Park YR, et al. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil.Biochem Biophys Res Commun, 2004, 320: 131-137.
  • 5Macdonald P. Diversity in translational regulation. Curr Opin Cell Biol,2001, 13:326-331.
  • 6Kitaura M, Suzuki N, lmai T, et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem, 1999, 274:27975-27980.
  • 7Berkman N, Ohnona S, Chung FK, et al. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol, 2001, 24:682-687.

同被引文献94

  • 1Chae SC, Park YR, Shim SC, et al. Eotaxin 3 gene polymorphisms are associated with rheumatoid arthritis in a Korean population. Hum Immunol, 2005, 66(33):314-320.
  • 2Amett FC, Edworty SM, Bloch DA, et al. The American rheu matism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31(3) :315-324.
  • 3Yudoh K, Matsuno H, Nakazawa F, et al. Reduced expression of the regulatory CD4+T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum, 2000, 43(3):617-627.
  • 4Chae SC, Lee YC, Park YR, et al. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochemical and Biophysical Research Communication, 2004, 320 (1):131-137.
  • 5Pease, James E. Asthma,allergy and chemokines. Current Drug Targets, 2006,7 (15) :31-34.
  • 6Hollak CE,van Weely S,van Oers MH. Marked elevation of plasma chitotriosidase acitivity[J].{H}Journal of Clinical Investigation,1994,(03):1288-1292.
  • 7Boot RG,Muijsers AO. Purifcation and characterization of human chitotriosidase,a novelmember of the chitinase family of proteins[J].{H}Journal of Biological Chemistry,1995,(05):2198-2202.
  • 8Boot RG,Blommaart EC,Swart E. Identification of a novel acidic mammalian chitinase distinct from chitotrisidase[J].{H}Journal of Biological Chemistry,2001,(09):6770-6778.
  • 9Aguilera B,Ghauharali-vander Vlugt K,Helmong MT. Transglycosidase activity of chitotriosidase:improved enzymatic assay for the human macrophage chitinase[J].{H}Journal of Biological Chemistry,2003,(42):40911-40916.
  • 10Zhu Z,Zheng T,Robert J. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation[J].{H}SCIENCE,2004,(5677):1678-1682.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部